AA
MIRM icon

ALPS Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

ALPS Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-49,128
Closed -$4.54M – 1199
2026
Q1 		$4.54M Buy
49,128
+7,031
+17% +$661K 0.02% 266
2025
Q4 		$3.33M Buy
42,097
+18,074
+75% +$1.3M 0.02% 311
2025
Q3 		$1.76M Sell
24,023
-2,613
-10% -$166K 0.01% 411
2025
Q2 		$1.36M Sell
26,636
-8,880
-25% -$395K 0.01% 426
2025
Q1 		$1.6M Sell
35,516
-3,306
-9% -$156K 0.01% 381
2024
Q4 		$1.61M Buy
38,822
+1,577
+4% +$65.7K 0.01% 376
2024
Q3 		$1.45M Buy
37,245
+486
+1% +$19.4K 0.01% 411
2024
Q2 		$1.26M Buy
36,759
+3,876
+12% +$102K 0.01% 418
2024
Q1 		$826K Buy
32,883
+1,204
+4% +$33.1K 0.01% 527
2023
Q4 		$935K Buy
+31,679
New +$959K 0.01% 497
2021
Q4 		– Sell
-37,401
Closed -$745K – 942
2021
Q3 		$745K Sell
37,401
-2,704
-7% -$44K 0.01% 424
2021
Q2 		$693K Sell
40,105
-14,926
-27% -$267K 0.01% 475
2021
Q1 		$1.09M Buy
55,031
+9,121
+20% +$175K 0.01% 389
2020
Q4 		$802K Buy
+45,910
New +$903K 0.01% 414

Other funds holding MIRM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

ALPS Advisors's MIRM Position: Q2 2026 in Review

ALPS Advisors sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 49,128 shares — an estimated $4.54M sold.

ALPS Advisors first reported a position in MIRM in Q4 2020 and held it in 14 quarters. The position peaked at $4.54M in Q1 2026. 114 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • ALPS Advisors reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • ALPS Advisors sold 49,128 Mirum Pharmaceuticals shares in Q2 2026, an estimated $4.54M.
  • ALPS Advisors first reported a position in Mirum Pharmaceuticals in Q4 2020 and held it in 14 quarters.
  • ALPS Advisors's Mirum Pharmaceuticals position peaked at $4.54M in Q1 2026.
  • 114 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.